[go: up one dir, main page]

PL1959988T3 - Zastosowanie laktoferyny bydlęcej do leczenia destrukcyjnego zapalenia błony śluzowej - Google Patents

Zastosowanie laktoferyny bydlęcej do leczenia destrukcyjnego zapalenia błony śluzowej

Info

Publication number
PL1959988T3
PL1959988T3 PL06724054T PL06724054T PL1959988T3 PL 1959988 T3 PL1959988 T3 PL 1959988T3 PL 06724054 T PL06724054 T PL 06724054T PL 06724054 T PL06724054 T PL 06724054T PL 1959988 T3 PL1959988 T3 PL 1959988T3
Authority
PL
Poland
Prior art keywords
mucous membrane
bovine lactoferrin
treating destructive
destructive inflammation
inflammation
Prior art date
Application number
PL06724054T
Other languages
English (en)
Inventor
Piera Valenti
Rosalba Paesano
Original Assignee
Microbo Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36950064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1959988(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Microbo Srl filed Critical Microbo Srl
Publication of PL1959988T3 publication Critical patent/PL1959988T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06724054T 2005-12-09 2006-04-05 Zastosowanie laktoferyny bydlęcej do leczenia destrukcyjnego zapalenia błony śluzowej PL1959988T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT002351A ITMI20052351A1 (it) 2005-12-09 2005-12-09 Nuovo uso farmaceutico delle transferrine e composizioni farmaceutiche derivate
EP06724054.9A EP1959988B2 (en) 2005-12-09 2006-04-05 Use of bovine lactoferrin for treating destructive inflammation of mucous membrane
PCT/EP2006/003106 WO2007065482A1 (en) 2005-12-09 2006-04-05 Use of transferrins for treating destructive inflammation of mucous membrane

Publications (1)

Publication Number Publication Date
PL1959988T3 true PL1959988T3 (pl) 2012-11-30

Family

ID=36950064

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06724054T PL1959988T3 (pl) 2005-12-09 2006-04-05 Zastosowanie laktoferyny bydlęcej do leczenia destrukcyjnego zapalenia błony śluzowej

Country Status (8)

Country Link
US (1) US9050323B2 (pl)
EP (1) EP1959988B2 (pl)
CN (1) CN101325965B (pl)
DK (1) DK1959988T3 (pl)
ES (1) ES2394344T5 (pl)
IT (1) ITMI20052351A1 (pl)
PL (1) PL1959988T3 (pl)
WO (1) WO2007065482A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101688067B (zh) 2007-07-12 2013-12-11 巴斯夫欧洲公司 基于珍珠岩薄片的干扰颜料
EP2189062B1 (en) * 2008-11-25 2013-07-17 Indena S.p.A. Plant extracts for use as phytochemicals
DK2418945T3 (en) 2009-04-15 2019-02-25 Bmg Pharma S P A Mineral salt-sulfonic acid compositions and methods of use
CN105727286A (zh) * 2010-04-23 2016-07-06 普若拜特有限公司 药用组合物
IT1406153B1 (it) 2010-12-23 2014-02-14 Microbo Srl Metodi di prevenzione e terapia per parti e nascite pretermine.
CN103160565A (zh) * 2011-12-09 2013-06-19 彩虹天健康科技研究(北京)有限责任公司 Unc-51激酶影响细胞运铁蛋白的胞吞作用
CN102766206A (zh) * 2012-07-02 2012-11-07 北京济福霖生物技术有限公司 一种改善缺铁性贫血的产品及其制备方法
FR2994657A1 (fr) 2012-08-23 2014-02-28 Henri Allain Nouvelles applications et utilisations de la lactoferrine
CN103550760A (zh) * 2013-11-07 2014-02-05 无锡科捷诺生物科技有限责任公司 乳铁蛋白在制备炎症因子偏高肥胖人群贫血药物中的应用
CN104888202A (zh) * 2014-05-22 2015-09-09 闫牧乔 一种治疗扁桃体炎的药物
US10172786B2 (en) * 2014-12-16 2019-01-08 Axim Biotechnologies, Inc. Oral care composition comprising cannabinoids
CN106377768A (zh) * 2016-08-24 2017-02-08 方雅悯 一种慢性咽炎膜剂及其制备方法
CN106310234A (zh) * 2016-08-24 2017-01-11 方雅悯 一种牛乳铁蛋白及水解或酶解物在治疗妇科疾病药物中的应用
RU2625739C1 (ru) * 2016-09-28 2017-07-18 Общество с ограниченной ответственностью Научно-производственное предприятие "Эксорб" Фармакологическая композиция на основе соединений железа
IT201700002411A1 (it) * 2017-01-11 2018-07-11 Bmg Pharma S R L Preparazione farmaceutica per il trattamento dell’ipoferremia e dell’anemia sideropenica
IT201900004599A1 (it) * 2019-03-27 2020-09-27 Microbo Srl Formulazioni topiche orali e/o orali sistemiche contenenti una miscela a base di lattoferrina, più efficace nella captazione del ferro, per la prevenzione e trattamento di varie patologie
CN111166872A (zh) * 2020-02-24 2020-05-19 中国科学院昆明动物研究所 转铁蛋白在制备免疫抑制剂类药物中的应用
IT202000022420A1 (it) * 2020-09-23 2022-03-23 Microbo Srl Formulazioni per somministrazioni topiche mucosali e/o orali sistemiche contenenti una miscela a base di lattoferrina, più efficace nella captazione del ferro, per la prevenzione e trattamento di varie patologie

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198419A (en) * 1989-12-08 1993-03-30 Immuno Japan Inc. Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
US6066469A (en) * 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
EP0559425B1 (en) * 1992-03-02 1999-01-07 Immuno Japan Inc. Use of proteins belonging to the transferrin/lactoferrin family for potentiating the immune system
JPH06145068A (ja) * 1992-04-02 1994-05-24 Imuno Japan:Kk 生体防御能賦活剤・感染症治療剤・生体防御能賦活性食品
JPH08217693A (ja) * 1995-02-17 1996-08-27 Yoshihisa Naito 新規医薬組成物
US20020016289A1 (en) 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
IT1278137B1 (it) * 1995-07-12 1997-11-17 Piera Valenti Utilizzo della lattoferrina per la terapia topica delle infezioni acute o recidivanti causate da "streptococcus pyogenes" o da altri
US5834424A (en) 1995-07-12 1998-11-10 Gambit International Limited Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus
US5869446A (en) * 1996-07-09 1999-02-09 Gambit International Limited Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
US6333311B1 (en) * 1997-02-03 2001-12-25 Pharming Useful properties of human lactoferrin and variants thereof
AU7368198A (en) † 1997-05-03 1998-11-27 Board Of Regents, The University Of Texas System Methods for preventing and treating the insult-induced metabolic imbalance in humans and other animals
US6188915B1 (en) † 1998-05-19 2001-02-13 Harris Corporation Bootstrapped, piecewise-asymptotic directivity pattern control mechanism setting weighting coefficients of phased array antenna
EP1068871A1 (en) 1999-07-07 2001-01-17 Jean-Paul Perraudin Novel methods and medicament for treating infections diseases involving microbial biofilms
AU4486501A (en) * 2000-03-27 2001-10-08 Pharming Intellectual Property Bv High dosage parenteral administration of lactoferrin
JP4683740B2 (ja) * 2001-02-15 2011-05-18 明治乳業株式会社 炎症に伴う症状の軽減剤
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
US7238661B2 (en) * 2002-05-24 2007-07-03 Agennix, Inc. Oral lactoferrin in the treatment of respiratory disorders
AU2003291206A1 (en) * 2002-12-04 2004-06-23 Agennix Incorporated Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease
AU2003298906A1 (en) * 2002-12-06 2004-06-30 Agennix Incorporated Oral lactoferrin in the treatment of sepsis
US20050075277A1 (en) † 2003-07-10 2005-04-07 Agennix Incorporated Use of lactoferrin in prophylaxis against infection and/or inflammation in immunosuppressed subjects

Also Published As

Publication number Publication date
CN101325965A (zh) 2008-12-17
WO2007065482A1 (en) 2007-06-14
ES2394344T5 (es) 2016-05-05
US20090156484A1 (en) 2009-06-18
DK1959988T3 (da) 2012-09-10
EP1959988B2 (en) 2016-03-09
EP1959988A1 (en) 2008-08-27
US9050323B2 (en) 2015-06-09
CN101325965B (zh) 2012-09-12
EP1959988B1 (en) 2012-05-23
ES2394344T3 (es) 2013-01-30
ITMI20052351A1 (it) 2007-06-10

Similar Documents

Publication Publication Date Title
PL1959988T3 (pl) Zastosowanie laktoferyny bydlęcej do leczenia destrukcyjnego zapalenia błony śluzowej
IL277322B (en) Compositions and methods for treating collagen-mediated diseases
ZA200900388B (en) Compositions and methods for the treatment of mucositis
EP1937298A4 (en) USE OF LACTOFERRIN FRAGMENTS AND HYDROLYSATES
PT2592072T (pt) Inibidores de proteína tirosina fosfatase humana e sua utilização
IL185396A0 (en) Methods of treating gastrointestinal inflammation
ZA200710598B (en) Treatment of inflammatory conditions
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
PL1874781T3 (pl) Dihydrotienopirymidyny do leczenia chorób zapalnych
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
ZA200705297B (en) Methods and compositions for treating amyloid related diseases
EP1959972A4 (en) PROCESS FOR TREATING OPEN INJURIES BY HYPOCHLOROUS ACID
EP2021005A4 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF INFLAMMATORY PAIN
IL211459A0 (en) Pancreatic polypeptide and variants thereof for use in the treatment of intestinal disorders
DK1933853T3 (da) Vævopbrydningsbehandling og sammensætning til brug derved
EP2262514B8 (en) Agents for promoting secretion and/or suppressing decrease of adiponectin
IL192083A0 (en) Bovine osteopontin formulations for the improvement of the wound healing process
GB0815632D0 (en) Compositions and methods for promoting the healing of tissue of multicellular organisms
GB0605715D0 (en) Treatment of laminitis
ZA200908989B (en) Enhancement of the efficacy of therapeutic proteins
FI20065514A0 (fi) Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi
EP1993564A4 (en) METHOD AND COMPOSITION FOR TREATING ALLERGIC DISEASES
WO2006094134A3 (en) Kim-1 antibodies for treatment of th2-mediated conditions
AP2007004141A0 (en) Recombinant expression of defensins in filamentousfunti
HUP0500947A2 (en) Composition for treatment of paradontosis